FUM.L Gross Margin

The Gross Margin of Futura Medical PLC (FUM.L) is 69.58%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

FUM.L Gross Margin - Historical Value

Date	Value
2024-12-31	69.58%
2023-12-31	57.22%

FUM.L Gross Margin - Peers Comparison

Ticker	Name	Value
APH.L	Alliance Pharma PLC	61.11%
GWPRF	GW Pharmaceuticals PLC	91.26%
NFX.L	Nuformix PLC	96.60%
STX.L	Shield Therapeutics PLC	30.78%
VEC.L	Vectura Group PLC	5320.04%
ALZCUR.ST	AlzeCure Pharma AB	7775.20%
GSK.L	GSK plc	71.90%
AB.PA	AB Science SA	60.52%
GRAY	Graybug Vision Inc	7775.20%
IMM.L	ImmuPharma PLC	100.00%
ATE.TO	Antibe Therapeutics Inc	36.56%
CXRXF	Advanz Pharma Corp Ltd	63.41%
AZN.L	AstraZeneca PLC	82.14%
GABA.ST	Gabather AB	7775.20%
HEPA	Hepion Pharmaceuticals Inc	7775.20%
KLAR.ST	Klaria Pharma Holding AB (publ)	100.00%
PLXP	PLx Pharma Inc	4146.00%
REDX.L	Redx Pharma PLC	88.82%
AGRX	Agile Therapeutics Inc	54.18%
ANNX.ST	Annexin Pharmaceuticals AB (publ)	7775.20%
HRTIS.HE	Herantis Pharma Oyj	-7.12%
INDV.L	Indivior PLC	85.27%
IRLAB A.ST	IRLAB Therapeutics AB	-44.03%
ZYNE	Zynerba Pharmaceuticals Inc	7775.20%
ACST.V	Acasti Pharma Inc	61.22%
DPH.L	Dechra Pharmaceuticals PLC	56.41%
HIK.L	Hikma Pharmaceuticals PLC	45.88%
OAT.WA	Oncoarendi Therapeutics SA	-26049.80%
SAR.L	Sareum Holdings PLC	-41.33%
SKIN.SW	Cassiopea SpA	100.00%
ALTHX.PA	Theranexus SA	-217.60%
ASAP.ST	Asarina Pharma AB (publ)	7775.20%
LYRA	Lyra Therapeutics Inc	7775.20%
NWRN.SW	Newron Pharmaceuticals SpA	98.26%